INTERNATIONAL PATENT: SHENZHEN PREGENE BIOPHARMA CO., LTD., 深圳普瑞金生物药业股份有限公司 FILES APPLICATION FOR "CHIMERIC ANTIGEN RECEPTOR TARGETING CD19 AND CD22 AND CAR-T CELL AND USE THEREOF"

Posted On: 2025-11-23

GENEVA, Nov. 23 -- SHENZHEN PREGENE BIOPHARMA CO., LTD. (Room 605, Building No. 1, Shenzhen Biomedical Innovation Industrial Park, No. 14 Jinhui Road Jinsha Community, Kengzi Street, Pingshan DistrictShenzhen, Guangdong 518122), 深圳普瑞金生物药业股份有限公司 (中国广东省深圳市坪山区坑梓街道金沙社区金辉路14号深圳市生物医药创新产业园区1号楼605) filed a patent application (PCT/CN2025/091633) for "CHIMERIC ANTIGEN RECEPTOR TARGETING...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SHENZHEN PREGENE BIOPHARMA CO., LTD., 深圳普瑞金生物药业股份有限公司 FILES APPLICATION FOR "CHIMERIC ANTIGEN RECEPTOR TARGETING CD19 AND CD22 AND CAR-T CELL AND USE THEREOF"